Christine Sacco, the Chief Financial Officer of Prestige Consumer Healthcare Inc. (NYSE:PBH), has sold shares amounting to approximately $2 million, according to a recent SEC filing. On November 12, Sacco sold 24,686 shares of the company's common stock at an average price of $82.01 per share. This transaction reduced her direct ownership of the company’s stock to 30,123 shares.
Additionally, the filing disclosed that Sacco acquired 24,686 shares through the exercise of employee stock options at a price of $30.56 per share. The options had vested in installments from May 2020 to May 2022. This acquisition was part of a routine stock option exercise, and the shares were subsequently sold on the same day.
In other recent news, Prestige Consumer Healthcare Inc. reported mixed results for the second quarter of 2025. The company's sales slightly declined to $284 million due to supply chain issues with the Clear Eyes brand. However, earnings per share (EPS) increased to $1.09, and the company generated $68 million in free cash flow. The decline in sales was offset by international growth, particularly with the Hydralyte brand and Canadian portfolio.
The company also reduced its debt by $40 million, achieving a leverage ratio of 2.7x. As part of its future plans, Prestige Consumer Healthcare is focusing on e-commerce expansion, which currently makes up 15% of its revenue. The company's outlook for the fiscal year includes projected revenues between $1.125 billion and $1.140 billion, and an adjusted EPS forecast of $4.40 to $4.46. These recent developments reflect the company's ability to navigate challenges and capitalize on growth opportunities.
InvestingPro Insights
Prestige Consumer Healthcare Inc. (NYSE:PBH) has been showing strong market performance, as evidenced by recent InvestingPro data. The company's stock has demonstrated impressive returns, with a 16.2% gain over the past month and a 20.53% increase over the last three months. This upward trend aligns with the CFO's recent stock transaction, potentially indicating a favorable outlook for the company.
InvestingPro Tips highlight that PBH is trading near its 52-week high, with the current price at 98.88% of its peak. This information, coupled with the strong recent returns, suggests that investors have been optimistic about the company's prospects. However, it's worth noting that one InvestingPro Tip cautions that the RSI suggests the stock may be in overbought territory, which could be relevant to investors considering the timing of potential transactions.
The company's financial health appears solid, with an InvestingPro Tip indicating that liquid assets exceed short-term obligations. This financial stability is further supported by the company's profitability over the last twelve months and analysts' predictions of continued profitability this year.
For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for PBH, providing a deeper understanding of the company's financial position and market dynamics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.